REGN Regeneron Pharmaceuticals

Sentiment & Price 1 ideas • 1 voices • 1 sources ▼
Sentiment Gauge
1
Bull
0
Bear
0
Watch
Bull 100% Bear 0%
Price & Sentiment
Loading chart...
Recent News Top Views ▼
No recent news for REGN
No theses available
Feed
All Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
News✓
Loading...
All directions✓
▲ Long✓
▼ Short✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
23:44
Apr 09
Jim Cramer Host, Mad Money CNBC
Cramer said Regeneron is "breaking out here," with CEO Leonard Schleifer doing an unbelievable job, and he likes the stock for its pipeline and earnings growth. Company has rising earnings, a strong product pipeline, and positive momentum, making it appealing for investment. Technical breakout and fundamental strength support a LONG position. Pipeline setbacks or regulatory challenges could hinder growth.
REGN

About REGN Analyst Coverage

Buzzberg tracks REGN (Regeneron Pharmaceuticals) across 1 sources. 1 bullish vs 0 bearish calls from 1 analysts. Sentiment: predominantly bullish (100%). 1 total trade ideas tracked.